These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 38149142)

  • 1. Misleading Presentation: Chest Pain Masking Euglycemic Diabetic Ketoacidosis Possibly Induced by Empagliflozin.
    Tiwari K; Sharma NR; Pokhrel M; Basnet A; Kaplan M
    Cureus; 2023 Nov; 15(11):e49402. PubMed ID: 38149142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SGLT-2 Inhibitor-Associated Euglycemic Diabetic Ketoacidosis: A Case Report and a Literature Review.
    Mahfooz RS; Khan MK; Al Hennawi H; Khedr A
    Cureus; 2022 Jun; 14(6):e26267. PubMed ID: 35911365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Case of Prolonged Recovery for Post-percutaneous Coronary Intervention (PCI) Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitor-Induced Euglycemic Diabetic Ketoacidosis in a 28-Year-Old.
    Petersen C; Gyabaah F; Sotelo J; Yohanna S; Deoker A
    Cureus; 2023 Sep; 15(9):e45180. PubMed ID: 37842482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Euglycemic diabetic ketoacidosis associated with ST segment elevation myocardial infarction following SGLT-2 inhibitor therapy.
    Baytuğan NZ; Çelik Aİ; Bezgin T; Çağdaş M
    Am J Emerg Med; 2023 Sep; 71():250.e1-250.e3. PubMed ID: 37451968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Euglycemic diabetic ketoacidosis associated with sodium-glucose cotransporter-2 inhibitor use: a case report and review of the literature.
    Diaz-Ramos A; Eilbert W; Marquez D
    Int J Emerg Med; 2019 Sep; 12(1):27. PubMed ID: 31488052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Literature Review of the Therapeutic Perspectives of Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitor-Induced Euglycemic Diabetic Ketoacidosis.
    Patel K; Nair A
    Cureus; 2022 Sep; 14(9):e29652. PubMed ID: 36320965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Self-Induced Euglycemic Diabetic Ketoacidosis: When to Stop the Drip.
    Zughaib MT; Patel K; Leka M; Affas S
    Cureus; 2022 Jan; 14(1):e21768. PubMed ID: 35251838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Empagliflozin-Associated Euglycemic Diabetic Ketoacidosis in a Patient With Type 2 Diabetes Mellitus.
    Chauhan S; Manov A; Dhillon GS; Shah P
    Cureus; 2023 Jan; 15(1):e33892. PubMed ID: 36819400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Euglycemic Diabetic Ketoacidosis Induced by Sodium-Glucose Cotransporter-2 Inhibitor Use and Coronary Angiography: A Case Report.
    VonTungeln CD; Al Bataineh M
    Cureus; 2024 Jan; 16(1):e52122. PubMed ID: 38344581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Late-Onset Euglycemic Diabetic Ketoacidosis in a Patient With Massive Stroke Requiring Decompressive Craniectomy: A Case Report.
    Hussaini SA; Aziz A; Musa M; Alamin M; Danjuma M
    Cureus; 2021 Oct; 13(10):e18629. PubMed ID: 34765377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Euglycemic Diabetic Ketoacidosis after a Single Dose of Empagliflozin in a Patient with Pancreatitis.
    Calçada MB; Fernandes L; Soares Costa R; Montezinho S; Martins Duarte F; Frutuoso L; Freitas AR
    Clin Pract; 2021 Apr; 11(2):216-218. PubMed ID: 33917274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diabetic Ketoacidosis in Patients with Type 2 Diabetes on Sodium-Glucose Cotransporter-2 Inhibitors - A Case Series.
    Sharma PV; Jobanputra YB; Lewin K; Bagatell S; Lichtstein DM
    Rev Recent Clin Trials; 2018; 13(2):156-160. PubMed ID: 29542418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SGLT-2 inhibitors and euglycemic diabetic ketoacidosis/diabetic ketoacidosis in FAERS: a pharmacovigilance assessment.
    He Z; Lam K; Zhao W; Yang S; Li Y; Mo J; Gao S; Liang D; Qiu K; Huang M; Wu J
    Acta Diabetol; 2023 Mar; 60(3):401-411. PubMed ID: 36576563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Rare Case of Empagliflozin-Induced Euglycemic Diabetic Ketoacidosis Obscured by Alkalosis.
    Fernandez Felix DA; Madrigal Loria G; Sharma S; Sharma S; Arias Morales CE
    Cureus; 2022 Jun; 14(6):e25818. PubMed ID: 35698468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sodium-glucose cotransporter 2 inhibitor-induced euglycemic diabetic ketoacidosis in a patient with coronavirus disease 2019: a case report.
    Yii ESS; Azli AW; Sitaram PN
    J Med Case Rep; 2022 Jan; 16(1):17. PubMed ID: 34983625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Empagliflozin induced euglycemic diabetic ketoacidosis. A case reports.
    Altowayan WM
    Ann Med Surg (Lond); 2022 Dec; 84():104879. PubMed ID: 36582864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Case of SGLT2 Inhibitor-Associated Euglycemic Diabetic Ketoacidosis Following Coronary Artery Bypass Surgery.
    Osafehinti DA; Okoli OJ; Karam JG
    AACE Clin Case Rep; 2021; 7(1):20-22. PubMed ID: 33851014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Euglycemic diabetic ketoacidosis: A missed diagnosis.
    Nasa P; Chaudhary S; Shrivastava PK; Singh A
    World J Diabetes; 2021 May; 12(5):514-523. PubMed ID: 33995841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Euglycemic Diabetic Ketoacidosis Caused by a Sodium-glucose Co-transporter (SGLT) 2 Inhibitor after Coronary Artery Bypass Grafting].
    Kameda Y; Kato M; Inoue B; Yamazaki S; Sahara N; Aoki T; Nagashima Y; Nemoto N; Anzai H; Araki W; Kobayashi N
    Kyobu Geka; 2019 May; 72(5):354-357. PubMed ID: 31268032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early detection of euglycemic ketoacidosis during thoracic surgery associated with empagliflozin in a patient with type 2 diabetes: A case report.
    Kitahara C; Morita S; Kishimoto S; Matsuno S; Uraki S; Takeshima K; Furukawa Y; Inaba H; Iwakura H; Ariyasu H; Furuta H; Nishi M; Akamizu T
    J Diabetes Investig; 2021 Apr; 12(4):664-667. PubMed ID: 32686282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.